GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benitec Biopharma Inc (FRA:BJ9) » Definitions » Issuance of Stock

Benitec Biopharma (FRA:BJ9) Issuance of Stock : €28.97 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Benitec Biopharma Issuance of Stock?

Benitec Biopharma's Issuance of Stock for the three months ended in Mar. 2024 was €0.00 Mil.

Benitec Biopharma's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was €28.97 Mil.

Benitec Biopharma Issuance of Stock Historical Data

The historical data trend for Benitec Biopharma's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benitec Biopharma Issuance of Stock Chart

Benitec Biopharma Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.00 21.37 - 16.51

Benitec Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 28.94 0.04 -

Benitec Biopharma Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €28.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Benitec Biopharma's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Benitec Biopharma (FRA:BJ9) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benitec Biopharma Inc (FRA:BJ9) » Definitions » Issuance of Stock
Comparable Companies
IFRX CMRX IOBT ASMB ENTX SER ELTX BCAB TLSA GRTS OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
BNTC:USA
Address
3940 Trust Way, Hayward, CA, USA, 94545
Website
https://www.benitec.com
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Benitec Biopharma (FRA:BJ9) Headlines

No Headlines